Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yves Poulin

Showing results (11-20 of 107) with videos related to

Pageof 11
Sort By:
Journal of Cutaneous Medicine and Surgery|September 23, 2009
The burden of psoriasis in Canada: insights from the pSoriasis Knowledge IN Canada (SKIN) surveyCharles W Lynde, Yves Poulin, Lyn Guenther, et al.
Dermatology and Therapy|February 4, 2014
Health-related quality of life worsens disproportionately to objective signs of psoriasis after withdrawal of adalimumab therapyYves Poulin, Pranav Sheth, Yihua Gu, et al.
Journal of Cutaneous Medicine and Surgery|July 26, 2011
Canadian guidelines for the management of plaque psoriasis: overviewKim Papp, Wayne Gulliver, Charles Lynde, et al.
Journal of the American Academy of Dermatology|December 29, 2016
Olumacostat glasaretil, a novel topical sebum inhibitor, in the treatment of acne vulgaris: A phase IIa, multicenter, randomized, vehicle-controlled studyRobert Bissonnette, Yves Poulin, Janice Drew, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|May 1, 2012
Evaluation of the French version of the 4-item index of the Acne-QoL (AcneQ4fr)Jerry Tan, Ashley O'Toole, Xuemao Zhang, et al.
Journal of Cutaneous Medicine and Surgery|July 21, 2010
Epidemiology of moderate-to-severe plaque psoriasis in a Canadian surveyed populationKim Papp, Fernando Valenzuela, Yves Poulin, et al.
Journal of the American Academy of Dermatology|March 25, 2014
Interleukin 17A: toward a new understanding of psoriasis pathogenesisCharles W Lynde, Yves Poulin, Ronald Vender, et al.
Journal of Cutaneous Medicine and Surgery|February 8, 2003
Pyodermatitis-pyostomatitis vegetans: two cases and a review of the literatureSimon Nigen, Yves Poulin, Linda Rochette, et al.
Journal of Drugs in Dermatology : JDD|May 10, 2014
Analysis of body regions and components of PASI scores during adalimumab or methotrexate treatment for patients with moderate-to-severe psoriasisAlexander A Navarini, Yves Poulin, Alan Menter, et al.
Journal of Cutaneous Medicine and Surgery|April 25, 2006
A favourable benefit/risk ratio with efalizumab: a review of the clinical evidenceYves Poulin, Kim A Papp, Wayne Carey, et al.
Pageof 11

Showing results (11-20 of 107) with videos related to

Sort By:
Pageof 11
Journal of Cutaneous Medicine and Surgery|September 23, 2009
The burden of psoriasis in Canada: insights from the pSoriasis Knowledge IN Canada (SKIN) surveyCharles W Lynde, Yves Poulin, Lyn Guenther, et al.
Dermatology and Therapy|February 4, 2014
Health-related quality of life worsens disproportionately to objective signs of psoriasis after withdrawal of adalimumab therapyYves Poulin, Pranav Sheth, Yihua Gu, et al.
Journal of Cutaneous Medicine and Surgery|July 26, 2011
Canadian guidelines for the management of plaque psoriasis: overviewKim Papp, Wayne Gulliver, Charles Lynde, et al.
Journal of the American Academy of Dermatology|December 29, 2016
Olumacostat glasaretil, a novel topical sebum inhibitor, in the treatment of acne vulgaris: A phase IIa, multicenter, randomized, vehicle-controlled studyRobert Bissonnette, Yves Poulin, Janice Drew, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|May 1, 2012
Evaluation of the French version of the 4-item index of the Acne-QoL (AcneQ4fr)Jerry Tan, Ashley O'Toole, Xuemao Zhang, et al.
Journal of Cutaneous Medicine and Surgery|July 21, 2010
Epidemiology of moderate-to-severe plaque psoriasis in a Canadian surveyed populationKim Papp, Fernando Valenzuela, Yves Poulin, et al.
Journal of the American Academy of Dermatology|March 25, 2014
Interleukin 17A: toward a new understanding of psoriasis pathogenesisCharles W Lynde, Yves Poulin, Ronald Vender, et al.
Journal of Cutaneous Medicine and Surgery|February 8, 2003
Pyodermatitis-pyostomatitis vegetans: two cases and a review of the literatureSimon Nigen, Yves Poulin, Linda Rochette, et al.
Journal of Drugs in Dermatology : JDD|May 10, 2014
Analysis of body regions and components of PASI scores during adalimumab or methotrexate treatment for patients with moderate-to-severe psoriasisAlexander A Navarini, Yves Poulin, Alan Menter, et al.
Journal of Cutaneous Medicine and Surgery|April 25, 2006
A favourable benefit/risk ratio with efalizumab: a review of the clinical evidenceYves Poulin, Kim A Papp, Wayne Carey, et al.
Pageof 11